Ed Arce Score: 27
Analyst at
H.C. Wainwright
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+89.3%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
57%
12 W / 9 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
35%
7 W / 13 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
10%
2 W / 18 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
5%
1 W / 19 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
55%
11 W / 9 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
57%
12 W / 9 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Dec 30, 2024 |
NewAmsterdam Pharma Company NV
NAMS
|
BUY |
$48.00
Est. +88%
|
$25.60 | $41.86 |
Miss
|
$19.90
-22.3%
|
| Nov 06, 2024 |
Ultragenyx Pharmaceutical Inc.
RARE
|
BUY |
$95.00
Est. +86%
|
$51.20 | $53.47 |
Miss
|
$17.16
-66.5%
|
| Sep 27, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$18.00
Est. +20%
|
$15.04 | $28.69 |
Target Met
|
$52.42
+248.5%
|
| Sep 23, 2024 |
Genfit - ADR
GNFT
|
BUY |
$13.00
Est. +158%
|
$5.03 | $6.42 |
Miss
|
$8.95
+77.9%
|
| Sep 17, 2024 |
Akero Therapeutics Inc
AKRO
|
BUY |
$50.00
Est. +85%
|
$26.97 | $58.40 |
Target Met
|
$54.65
+102.6%
|
| Sep 13, 2024 |
Pliant Therapeutics Inc
PLRX
|
BUY |
$38.00
Est. +221%
|
$11.84 | $16.07 |
Miss
|
$0.85
-92.8%
|
| Sep 06, 2024 |
Aurinia Pharmaceuticals Inc
AUPH
|
BUY |
$13.00
Est. +88%
|
$6.91 | $12.80 |
Precision Hit (±3%)
|
$17.11
+147.6%
|
| Aug 14, 2024 |
Cidara Therapeutics Inc
CDTX
|
BUY |
$24.00
Est. +273%
|
$6.43 | $66.95 |
Target Met
|
$221.38
+3342.9%
|
| Aug 05, 2024 |
Ardelyx Inc
ARDX
|
BUY |
$11.00
Est. +82%
|
$6.05 | $7.18 |
Miss
|
$3.29
-45.6%
|
| Aug 02, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$20.00
Est. +116%
|
$9.24 | $25.29 |
Target Met
|
$52.42
+467.3%
|
| Jul 05, 2024 |
Ardelyx Inc
ARDX
|
BUY |
$10.00
Est. +89%
|
$5.29 | $7.18 |
Miss
|
$3.29
-37.8%
|
| Jul 02, 2024 |
Arcturus Therapeutics Holdings Inc
ARCT
|
BUY |
$60.00
Est. +1675%
|
$3.38 | $25.88 |
Miss
|
$10.87
+221.6%
|
| Jun 17, 2024 |
Mirum Pharmaceuticals Inc
MIRM
|
BUY |
$66.00
Est. +113%
|
$30.99 | $54.23 |
Miss
|
$96.97
+212.9%
|
| May 10, 2024 |
89bio Inc
ETNB
|
BUY |
$29.00
Est. +222%
|
$9.00 | $11.84 |
Miss
|
$14.84
+64.9%
|
| May 07, 2024 |
Pliant Therapeutics Inc
PLRX
|
BUY |
$36.00
Est. +161%
|
$13.79 | $16.07 |
Miss
|
$0.85
-93.8%
|
| Apr 24, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$19.00
Est. +247%
|
$5.48 | $25.29 |
Target Met
|
$52.42
+856.6%
|
| Mar 28, 2024 |
Akebia Therapeutics Inc.
AKBA
|
BUY |
$6.00
Est. +203%
|
$1.98 | $2.89 |
Miss
|
$0.69
-64.9%
|
| Mar 14, 2024 |
Mirum Pharmaceuticals Inc
MIRM
|
BUY |
$58.00
Est. +106%
|
$28.17 | $54.23 |
Miss
|
$96.97
+244.2%
|
| Oct 11, 2023 |
Akero Therapeutics Inc
AKRO
|
BUY |
$40.00
Est. +166%
|
$15.04 | $29.87 |
Miss
|
$54.65
+263.4%
|
| Jul 13, 2023 |
Intercept Pharmaceuticals Inc
ICPT
|
BUY |
$19.00
Est. +63%
|
$11.63 | $19.01 |
Bullseye Hit (±1%)
|
$19.00
+63.4%
|
| Mar 17, 2022 |
Arbutus Biopharma Corp
ABUS
|
BUY |
$8.50
Est. +181%
|
$3.02 | - | - |
$4.06
+34.4%
|
NewAmsterdam Pharma Company NV
NAMS
Dec 30, 2024
Signal & Target
BUY
$48.00
Start Price
$25.60
Best Price (1Y)
$41.86
Current Price
$19.90
Return
-22.3%
Ultragenyx Pharmaceutical Inc.
RARE
Nov 06, 2024
Signal & Target
BUY
$95.00
Start Price
$51.20
Best Price (1Y)
$53.47
Current Price
$17.16
Return
-66.5%
Travere Therapeutics Inc
TVTX
Sep 27, 2024
Signal & Target
BUY
$18.00
Start Price
$15.04
Best Price (1Y)
$28.69
Current Price
$52.42
Return
+248.5%
Genfit - ADR
GNFT
Sep 23, 2024
Signal & Target
BUY
$13.00
Start Price
$5.03
Best Price (1Y)
$6.42
Current Price
$8.95
Return
+77.9%
Akero Therapeutics Inc
AKRO
Sep 17, 2024
Signal & Target
BUY
$50.00
Start Price
$26.97
Best Price (1Y)
$58.40
Current Price
$54.65
Return
+102.6%
Pliant Therapeutics Inc
PLRX
Sep 13, 2024
Signal & Target
BUY
$38.00
Start Price
$11.84
Best Price (1Y)
$16.07
Current Price
$0.85
Return
-92.8%
Aurinia Pharmaceuticals Inc
AUPH
Sep 06, 2024
Signal & Target
BUY
$13.00
Start Price
$6.91
Best Price (1Y)
$12.80
Current Price
$17.11
Return
+147.6%
Cidara Therapeutics Inc
CDTX
Aug 14, 2024
Signal & Target
BUY
$24.00
Start Price
$6.43
Best Price (1Y)
$66.95
Current Price
$221.38
Return
+3342.9%
Ardelyx Inc
ARDX
Aug 05, 2024
Signal & Target
BUY
$11.00
Start Price
$6.05
Best Price (1Y)
$7.18
Current Price
$3.29
Return
-45.6%
Travere Therapeutics Inc
TVTX
Aug 02, 2024
Signal & Target
BUY
$20.00
Start Price
$9.24
Best Price (1Y)
$25.29
Current Price
$52.42
Return
+467.3%
Ardelyx Inc
ARDX
Jul 05, 2024
Signal & Target
BUY
$10.00
Start Price
$5.29
Best Price (1Y)
$7.18
Current Price
$3.29
Return
-37.8%
Arcturus Therapeutics Holdings Inc
ARCT
Jul 02, 2024
Signal & Target
BUY
$60.00
Start Price
$3.38
Best Price (1Y)
$25.88
Current Price
$10.87
Return
+221.6%
Mirum Pharmaceuticals Inc
MIRM
Jun 17, 2024
Signal & Target
BUY
$66.00
Start Price
$30.99
Best Price (1Y)
$54.23
Current Price
$96.97
Return
+212.9%
89bio Inc
ETNB
May 10, 2024
Signal & Target
BUY
$29.00
Start Price
$9.00
Best Price (1Y)
$11.84
Current Price
$14.84
Return
+64.9%
Pliant Therapeutics Inc
PLRX
May 07, 2024
Signal & Target
BUY
$36.00
Start Price
$13.79
Best Price (1Y)
$16.07
Current Price
$0.85
Return
-93.8%
Travere Therapeutics Inc
TVTX
Apr 24, 2024
Signal & Target
BUY
$19.00
Start Price
$5.48
Best Price (1Y)
$25.29
Current Price
$52.42
Return
+856.6%
Akebia Therapeutics Inc.
AKBA
Mar 28, 2024
Signal & Target
BUY
$6.00
Start Price
$1.98
Best Price (1Y)
$2.89
Current Price
$0.69
Return
-64.9%
Mirum Pharmaceuticals Inc
MIRM
Mar 14, 2024
Signal & Target
BUY
$58.00
Start Price
$28.17
Best Price (1Y)
$54.23
Current Price
$96.97
Return
+244.2%
Akero Therapeutics Inc
AKRO
Oct 11, 2023
Signal & Target
BUY
$40.00
Start Price
$15.04
Best Price (1Y)
$29.87
Current Price
$54.65
Return
+263.4%
Intercept Pharmaceuticals Inc
ICPT
Jul 13, 2023
Signal & Target
BUY
$19.00
Start Price
$11.63
Best Price (1Y)
$19.01
Current Price
$19.00
Return
+63.4%
Arbutus Biopharma Corp
ABUS
Mar 17, 2022
Signal & Target
BUY
$8.50
Start Price
$3.02
Best Price (1Y)
-
Current Price
$4.06
Return
+34.4%